Latest Price,solid-phase peptide synthesis

The realm of peptide synthesis has been revolutionized by solid phase peptide synthesis (SPPS), a methodology that has dramatically accelerated the creation of peptides and polypeptides. This technique, pioneered by R. Bruce Merrifield, who was awarded the Nobel Prize in Chemistry in 1984 for his groundbreaking work, involves anchoring the peptide chain to an insoluble polymer support, or resin, and sequentially adding amino acids. This approach contrasts with traditional liquid phase peptide synthesis, which is often more arduous and time-consuming, requiring extensive purification steps like recrystallization or column chromatography after each coupling. The solid phase nature of SPPS allows for efficient washing to remove excess reagents and byproducts, significantly streamlining the synthesis process.

A prime example of the power and precision of solid phase techniques is the total synthesis of complex peptides, such as the nukacin ISK-1. While the specific details of the nukacin ISK-1 total synthesis are beyond the scope of this general overview, its successful realization underscores the advancements in peptide synthesis methodologies. The ability to perform a complete synthesis of such intricate molecules relies heavily on the robust and scalable nature of solid phase peptide synthesis.

The Pillars of Solid Phase Peptide Synthesis

The efficacy of SPPS hinges on several key components and strategies. The choice of resin is paramount, with common options including polystyrene-based resins like Merrifield resin, Wang resin, or Rink Amide resin. These resins are functionalized to allow a covalent attachment of the first amino acid, typically via its C-terminus. The solid phase principle allows for the accumulation of the peptide chain on the resin.

Two primary chemical strategies dominate SPPS: the Boc/Bzl (tert-butyloxycarbonyl/benzyl) strategy and the Fmoc/tBu (9-fluorenylmethyloxycarbonyl/tert-butyl) strategy. The Fmoc/tBu strategy is widely favored due to its milder deprotection conditions. In this approach, the $\alpha$-amino group of incoming amino acids is protected by the Fmoc group, which is labile to a base, typically piperidine. The side chains of amino acids are protected by acid-labile tert-butyl (tBu) based protecting groups. This orthogonal protection scheme ensures that only the $\alpha$-amino group is deprotected at each coupling cycle, allowing for the sequential addition of protected amino acids. The Fmoc-based solid-phase peptide synthesis offers advantages in terms of compatibility with base-labile amino acid side chain protecting groups and ease of monitoring reaction progress.

The Synthesis Cycle: A Step-by-Step Process

The core of SPPS involves a repetitive cycle of deprotection and coupling. To achieve a complete peptide sequence, this cycle is performed for each amino acid residue to be incorporated.

1. Resin Swelling: The solid phase support, the resin, is first swollen in an appropriate solvent, usually dimethylformamide (DMF) or N-methylpyrrolidone (NMP), to ensure accessibility of the reaction sites. A typical scale for a synthesis might involve using 300 mg of resin for a 0.1 mmol scale synthesis.

2. Deprotection: The N-terminal protecting group (e.g., Fmoc) of the growing peptide chain attached to the resin is removed. For Fmoc chemistry, this is achieved by treatment with a solution of piperidine in DMF. This exposes the free amine group on the N-terminus, ready for the next coupling step.

3. Washing: Following deprotection, the resin is thoroughly washed with solvent to remove the deprotecting reagent and any liberated byproducts. This step is crucial for preventing side reactions in subsequent steps.

4. Activation and Coupling: The incoming protected amino acid is activated to enhance its reactivity. Common coupling reagents include carbodiimides like DCC (dicyclohexylcarbodiimide), DIC (diisopropylcarbodiimide), or EDAC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide), often in combination with additives like HOBt (hydroxybenzotriazole) or HOAt (hydroxyazabenzotriazole). Alternatively, pre-activated amino acid derivatives or uronium/phosphonium-based coupling reagents such as HATU (1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate) or HBTU (O-benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate) are frequently employed. The activated amino acid is then added to the resin, and the reaction proceeds to form a new peptide bond. The coupling reaction should ideally be complete within a short timeframe, often around 1 hour, though this can vary. Monitoring the coupling efficiency, for instance, by a Ninhydrin test on a small aliquot of resin, is critical. If coupling is incomplete